The SPD489-344, Phase 3, Multicenter, Randomized, Double

Project: Research project

Project Details

Description

The SPD489-344, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety and Tolerability of SPD489 in Adults Aged 18-55
StatusFinished
Effective start/end date12/11/125/31/14

Funding

  • Shire Development Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.